NTUS Stock Alert: Halper Sadeh LLP Investigating Whether Sale of Natus Medical Incorporated Is Fair to Shareholders

NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Natus Medical Incorporated (NASDAQ: NTUS) to an ArchiMed affiliate for $33.50 cash per share is fair to Natus Medical shareholders.

Halper Sadeh encourages Natus Medical shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]

The investigation focuses on whether Natus Medical and its board of directors violated federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for the shareholders of Natus Medical; (2) determine whether ArchiMed is paying less for Natus Medical; and (3) disclose all material information necessary for Natus Medical shareholders to adequately assess and value the Merger Consideration. On behalf of Natus Medical shareholders, Halper Sadeh LLP may seek increased shareholder consideration, additional disclosures and information regarding the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Natus Medical shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]

Halper Sadeh LLP represents investors around the world who have been victims of securities fraud and corporate misconduct. Our lawyers have been instrumental in enacting corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Lawyer advertisement. Previous results do not guarantee a similar result.

Comments are closed.